Kaneko T, Ikeda H, Fu L, Nishiyama H, Okubo T
First Department of Internal Medicine, Yokohama City University School of Medicine, Japan.
Eur J Pharmacol. 1995 Mar 16;292(3-4):251-5. doi: 10.1016/0926-6917(95)90029-2.
In the present study, we asked whether platelet-activating factor (PAF) mediates the ozone-induced increase in airway microvascular leakage. To answer this question, we examined the effect of a PAF receptor antagonist on the ozone-induced increase in airway microvascular leakage quantified by the extravasation of Evans blue dye in the guinea pig trachea and main bronchi. Guinea pigs were pretreated with the PAF receptor antagonist, E6123 ((S)-(+)-6-(2-chlorophenyl)-3-cyclopropane-carbonyl-8,11-dimethyl-2,3,4, 5- tetrahydro-8H-pyrido[4',3':4,5]thieno[3,2- f][1,2,4]triazolo[4,3-a][1,4]diazepine) (0.01, 0.1 and 1.0 mg/kg i.v.) and then exposed to 3 ppm ozone for 30 min. The PAF receptor antagonist significantly reduced the ozone-induced increase in microvascular leakage in a dose-dependent manner in both the trachea and main bronchi. Our results indicate that PAF mediates the ozone-induced increase in airway microvascular leakage. We therefore suggest that PAF may be involved in ozone-induced airway inflammation.
在本研究中,我们探究了血小板活化因子(PAF)是否介导臭氧诱导的气道微血管渗漏增加。为回答这个问题,我们通过检测豚鼠气管和主支气管中伊文思蓝染料外渗来量化气道微血管渗漏,研究了PAF受体拮抗剂对臭氧诱导的气道微血管渗漏增加的影响。豚鼠预先接受PAF受体拮抗剂E6123((S)-(+)-6-(2-氯苯基)-3-环丙烷甲酰基-8,11-二甲基-2,3,4,5-四氢-8H-吡啶并[4',3':4,5]噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓)(静脉注射0.01、0.1和1.0mg/kg)处理,然后暴露于3ppm臭氧中30分钟。PAF受体拮抗剂在气管和主支气管中均以剂量依赖性方式显著降低了臭氧诱导的微血管渗漏增加。我们的结果表明,PAF介导了臭氧诱导的气道微血管渗漏增加。因此,我们认为PAF可能参与了臭氧诱导的气道炎症。